EN
HI

SHILPA MEDICARE Share price

SHILPAMED

HealthcareMid

735.6

33.15 (4.72%)
NSE
BSE
Last updated on 22 May, 2025 | 15:52 IST
BUYSELL
Today's High

747.00

Today's Low

704.10

52 Week Low

417.60

52 Week High

959.50

The current prices are delayed, login to your account for live prices

Shilpa Medicare Chart

SHILPA MEDICARE Share Key Metrics

Volume
4.18 L
Market Cap
7193.50 CR
LTQ@LTP
40@735.60
ATP
729.83
Var Margin
23.52 %
Circuit Range
562-842.9
Delivery %
39.47 %
Value
30.50 CR
ASM/GSM
No
Market Lot
1

SHILPA MEDICARE Futures & Options

Data Not Found

SHILPA MEDICARE Corporate Actions

DateAgenda
2025-05-26Audited Results & Final Dividend
2025-02-10Quarterly Results
DateEvent TypeAgenda
2025-05-26Board MeetingAudited Results & Final Dividend
2025-02-10Board MeetingQuarterly Results

SHILPA MEDICARE News

Shilpa Medicare shares rise 6% on CEP approvals from EDQM

Nov 19 2024 13:36:51

AstraZeneca Pharma, Themis Medicare, PG Electroplast, Shilpa Medicare in Focus | Stocks On Radar

Nov 19 2024 11:51:51

Shilpa Medicare share jumps 8% as Q2 earnings impress

Nov 14 2024 11:36:55

Shilpa Medicare share jumps 8% as Q2 earnings impress

Nov 14 2024 11:31:54
Read More

About SHILPA MEDICARE AboutThe

NSE : 17752  
BSE : 530549  
ISIN : INE790G01031  

Shilpa Antibiotics Ltd was incorporated as a PrivateLimited Company in November 1987. The commercialproduction of the Company had started in November 1989.The Company was initially producing Trimethoprim IP/BP anantibiotic bulk drug. The technology for the bulk drug wasdeveloped in house. During the first year of its operationthe Company had installed production facilities tomanufacture Trimethoprim Apart from selling on its own theCompany had also started manufacturing the product forother reputed Companies like Eskayef Limited Bombay Drugsand Pharmas Limited Bombay Drug House Ltd. US VitaminsLtd Sandoz India Ltd etc for their export commitments.During 1992 the Company had installed productionfacilities for manufacture of Sodium Methoxide. Thetechnology for the same had also been developed in house.During the same year the Company secured Export orders fromStellar Exports Limited Glaxo Limited and Deepak NitriteLimited for Trimethoprim. Since then the company hasstarted exporting on its own. The Company thus startedmanufacturing for both export and domestic markets since1992. It has obtained World Health Organisation-GoodManufacturing Practices (GMP) Certificate. It has alsobeen exporting its products to hard currency areas.The Company now proposes to embark upon an expansionproject which involves the addition of one more bulk drugto its existing product range viz; Norfloxcin and expansionof the production capacity of the existing product of theCompany viz; Sodium Methoxide and Trimethoprim. TheCompany also proposes to manufacture 1-MethylAmino-1-Methyl Thio-2-Nitro Ethane a drug intermediateused in the manufacture of Ranitidine an anti-ulcer drug.To raise the necessary resources to finance the expansionproject of the Company the Company was converted into aPublic Limited Company in November 1993.As the company''s sales are comparatively more in theSeptember to March period therefore to reduce theadministrative bottlenecks in the timely preparation ofannual results the company changed its accounting yearfrom March end to September end.Objects of the CompanyThe relevant objects of the company as set out in thememorandum of association of the company are :Main Objects1. To carry on in India or elsewhere the industry trade orbusiness of manufacturers Traders Dealers AgentsSuppliers Licensors Licensees Loan Licenses ImportersExporters Consultants Discoverers Inventors andProducers of Drugs Bulk Drugs PharmaceuticalsPharmaceutical Formulations Alcohol Bended LaboratoryPreparations and general medicinal preparation and ortheir by-products and packing and re-packing of the above.

SHILPA MEDICARE Management

NamePosition
Mr. Omprakash Inani Chairman
Mr. Vishnukant C Bhutada Managing Director
Mr. Kalakota Sharath Reddy Whole Time Director
Mr. Hetal Madhukant Gandhi Independent Director
Mr. Arvind Vasudeva Independent Director
Read More

SHILPA MEDICARE FAQs

SHILPA MEDICARE शेयर का खरीद मूल्य 735.6 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

SHILPA MEDICARE शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

SHILPA MEDICARE शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 77.85 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

SHILPA MEDICARE शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.91 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

SHILPA MEDICARE शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.81 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

SHILPA MEDICARE का मार्केट कैप 7193.50 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

SHILPA MEDICARE शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 959.50 और 417.60 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।